DK453488D0 - Fremgangsmaade til fremstilling af en lamineret opbygning inden i en lukket beholder - Google Patents

Fremgangsmaade til fremstilling af en lamineret opbygning inden i en lukket beholder

Info

Publication number
DK453488D0
DK453488D0 DK453488A DK453488A DK453488D0 DK 453488 D0 DK453488 D0 DK 453488D0 DK 453488 A DK453488 A DK 453488A DK 453488 A DK453488 A DK 453488A DK 453488 D0 DK453488 D0 DK 453488D0
Authority
DK
Denmark
Prior art keywords
subunits
preparing
procedure
dispersions
melt
Prior art date
Application number
DK453488A
Other languages
English (en)
Other versions
DK175797B1 (da
DK453488A (da
Inventor
Patricia S Campbell
David J Enscore
Robert M Gale
Arnold Kaufman
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22189156&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK453488(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of DK453488D0 publication Critical patent/DK453488D0/da
Publication of DK453488A publication Critical patent/DK453488A/da
Application granted granted Critical
Publication of DK175797B1 publication Critical patent/DK175797B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
DK198804534A 1987-08-13 1988-08-12 Fremgangsmåde til fremstilling af en lamineret opbygning inden i en lukket beholder DK175797B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/085,052 US4832953A (en) 1987-08-13 1987-08-13 Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
US8505287 1987-08-13

Publications (3)

Publication Number Publication Date
DK453488D0 true DK453488D0 (da) 1988-08-12
DK453488A DK453488A (da) 1989-02-14
DK175797B1 DK175797B1 (da) 2005-02-28

Family

ID=22189156

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198804534A DK175797B1 (da) 1987-08-13 1988-08-12 Fremgangsmåde til fremstilling af en lamineret opbygning inden i en lukket beholder

Country Status (14)

Country Link
US (1) US4832953A (da)
EP (1) EP0304227B1 (da)
JP (1) JP2610314B2 (da)
KR (1) KR910000411B1 (da)
AT (1) ATE86126T1 (da)
AU (1) AU600634B2 (da)
CA (1) CA1331340C (da)
DE (1) DE3878781T2 (da)
DK (1) DK175797B1 (da)
ES (1) ES2042754T3 (da)
GR (1) GR3008020T3 (da)
IE (1) IE61680B1 (da)
NZ (1) NZ225766A (da)
PT (1) PT88269B (da)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308621A (en) * 1991-02-18 1994-05-03 Commonwealth Scientific And Industrial Research Organisation Ascorbic acid composition and transdermal administration method
DE4223360C1 (da) * 1992-07-16 1993-04-08 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
US5827245A (en) * 1992-07-16 1998-10-27 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising the active subtance 17-β-Estradiol (Anhydrous)
WO1996008270A2 (en) * 1994-09-13 1996-03-21 Magainin Pharmaceuticals Inc. Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds
US5714162A (en) * 1994-09-16 1998-02-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Scopolamine patch
US5662928A (en) * 1995-04-21 1997-09-02 Ciba-Geigy Corporation Method for the prevention or removal of crystalline scopolamine in a non-aqueous matrix of a transdermal system
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
WO1997020550A2 (en) * 1995-12-01 1997-06-12 Alza Corporation Improved method for preventing crystal formation in a dispersion of a liquid in a matrix
US6238700B1 (en) * 1995-12-01 2001-05-29 Alza Corporation Method for preventing crystal formation in a dispersion of a liquid in a matrix
ES2183203T3 (es) * 1996-07-03 2003-03-16 Alza Corp Dispositivos de administracion de farmacos y procedimiento de preparacion.
KR100483913B1 (ko) * 1996-07-03 2005-09-02 알자 코포레이션 약물송달장치
US6007837A (en) * 1996-07-03 1999-12-28 Alza Corporation Drug delivery devices and process of manufacture
US6174545B1 (en) 1997-07-01 2001-01-16 Alza Corporation Drug delivery devices and process of manufacture
DE19738643C2 (de) 1997-09-04 2001-10-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase und Verfahren zu seiner Herstellung
GB9720470D0 (en) 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
US6918901B1 (en) 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
DK1037687T3 (da) 1997-12-11 2009-01-26 Alza Corp Anordning til at forbedre et middels transdermale strömning
WO1999029364A1 (en) * 1997-12-11 1999-06-17 Alza Corporation Device for enhancing transdermal agent flux
DK1037686T3 (da) * 1997-12-11 2006-01-02 Alza Corp Apparat til forögelse af transdermal gennemströmning af midler
EP1911488A3 (en) 1997-12-11 2008-12-03 Alza Corporation Device for enhancing transdermal agent flux
CN100388916C (zh) 1997-12-22 2008-05-21 阿尔扎有限公司 用于控释药物传递装置的速率控制膜
CA2345492C (en) * 1998-09-29 2009-12-22 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
US20070196490A1 (en) * 1999-01-22 2007-08-23 Powderject Research Limited Method of enhancing needleless transdermal powered drug delivery
ES2253278T3 (es) 1999-12-10 2006-06-01 Alza Corporation Dispositivo y procedimiento para mejorar la perforacion cutanea con microprotuberancias.
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
JP2004505931A (ja) * 2000-08-03 2004-02-26 アンタレス　ファルマ　アイピーエル　アクチェンゲゼルシャフト 適切な治療水準を保証する活性化合物の経皮投与及び／又は経粘膜投与のための新規組成物
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
MXPA06003316A (es) 2003-10-10 2006-06-08 Antares Pharma Ipl Ag Formulacion farmaceutica transdermica para minimizar los residuos en la piel.
US7387788B1 (en) 2003-10-10 2008-06-17 Antares Pharma Ipl Ag Pharmaceutical compositions of nicotine and methods of use thereof
US7425340B2 (en) * 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
KR100699582B1 (ko) 2005-07-11 2007-03-23 삼성전기주식회사 출력 버퍼회로
AU2006280511A1 (en) * 2005-08-12 2007-02-22 Astrazeneca Ab Process
US7888422B2 (en) 2005-11-09 2011-02-15 Mylan Technologies Inc. Long-wearing removable pressure sensitive adhesive
NZ571460A (en) * 2006-04-21 2010-10-29 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
WO2008067991A2 (en) * 2006-12-08 2008-06-12 Antares Pharma Ipl Ag Skin-friendly drug complexes for transdermal administration
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
EP2384432B1 (en) 2007-06-21 2016-12-28 Gen-Probe Incorporated Instrument and receptacles for performing processes
US9017301B2 (en) * 2007-09-04 2015-04-28 Mylan Technologies, Inc. Transdermal drug delivery systems comprising a coated release liner
NZ589542A (en) * 2008-05-30 2012-10-26 Mylan Inc Transdermal drug delivery system comprising an active agent in amorphous form and polyvinylpyrrolidone
WO2010042152A2 (en) * 2008-10-06 2010-04-15 Mylan Technologies, Inc. Amorphous rotigotine transdermal system
US9186334B2 (en) 2009-05-04 2015-11-17 Nuvo Research Inc. Heat assisted lidocaine and tetracaine for transdermal analgesia
EP2427160A4 (en) 2009-05-04 2012-12-19 Zars Pharma Inc METHOD FOR TREATING PAIN RELATED TO NEUROMAS, NERVE CLAIMS AND OTHER SUFFERING PAINS
DE102009052972A1 (de) 2009-11-12 2011-09-15 Lts Lohmann Therapie-Systeme Ag Verfahren zur Verhinderung der Kristallisation von Arzneistoffen in einem Polymerfilm
JP5766475B2 (ja) * 2010-03-30 2015-08-19 日東電工株式会社 貼付製剤およびその製造方法
MX2012012317A (es) 2010-04-28 2012-11-21 Kimberly Clark Co Arreglo de microagujas moldeado por inyeccion y metodo para formar el arreglo de microagujas.
US9586044B2 (en) 2010-04-28 2017-03-07 Kimberly-Clark Worldwide, Inc. Method for increasing the permeability of an epithelial barrier
JP5860033B2 (ja) 2010-04-28 2016-02-16 キンバリー クラーク ワールドワイド インコーポレイテッド ｓｉＲＮＡ送達用の医療デバイス
RU2585159C2 (ru) 2010-04-28 2016-05-27 Кимберли-Кларк Ворлдвайд, Инк. Устройство доставки лекарственного средства, применяемого при ревматоидном артрите
US8696637B2 (en) 2011-02-28 2014-04-15 Kimberly-Clark Worldwide Transdermal patch containing microneedles
CA2790749A1 (en) * 2011-09-29 2013-03-29 Nitto Denko Corporation Manufacturing method of patch preparation
MX343262B (es) 2011-10-27 2016-10-28 Kimberly Clark Co Administración transdérmica de agentes bioactivos de alta viscosidad.
JP5270035B1 (ja) 2012-12-06 2013-08-21 久光製薬株式会社 貼付剤及びその製造方法
JP5307931B1 (ja) 2012-12-27 2013-10-02 久光製薬株式会社 貼付剤及びその製造方法
JP5415645B1 (ja) 2013-06-28 2014-02-12 久光製薬株式会社 貼付剤の製造方法、貼付剤及び包装体
DE102018120506A1 (de) * 2017-10-20 2019-04-25 Amw Gmbh Stabilisiertes transdermales Darreichungssystem
JPWO2020189323A1 (da) * 2019-03-19 2020-09-24

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4436741A (en) * 1975-12-08 1984-03-13 Alza Corporation Method for administering scopolamine transdermally
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4262003A (en) * 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally
US4230105A (en) * 1978-11-13 1980-10-28 Merck & Co., Inc. Transdermal delivery of drugs
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
US4532244A (en) * 1984-09-06 1985-07-30 Innes Margaret N Method of treating migraine headaches
JPH0742228B2 (ja) * 1985-11-13 1995-05-10 日東電工株式会社 医薬製剤

Also Published As

Publication number Publication date
PT88269A (pt) 1989-06-30
EP0304227A2 (en) 1989-02-22
NZ225766A (en) 1990-06-26
DE3878781T2 (de) 1993-06-09
DE3878781D1 (de) 1993-04-08
EP0304227A3 (en) 1989-06-28
DK175797B1 (da) 2005-02-28
CA1331340C (en) 1994-08-09
AU2060788A (en) 1989-02-16
US4832953A (en) 1989-05-23
KR910000411B1 (ko) 1991-01-25
GR3008020T3 (da) 1993-09-30
ATE86126T1 (de) 1993-03-15
JP2610314B2 (ja) 1997-05-14
DK453488A (da) 1989-02-14
IE61680B1 (en) 1994-11-16
EP0304227B1 (en) 1993-03-03
ES2042754T3 (es) 1993-12-16
IE882424L (en) 1989-02-13
JPS6466113A (en) 1989-03-13
PT88269B (pt) 1996-01-31
KR890003354A (ko) 1989-04-14
AU600634B2 (en) 1990-08-16

Similar Documents

Publication Publication Date Title
DK453488D0 (da) Fremgangsmaade til fremstilling af en lamineret opbygning inden i en lukket beholder
ES403104A1 (es) Un metodo de fabricacion de un material ceramico.
Rodrigues et al. Isothermal and non-isothermal crystallization of a fresnoite glass
GB949233A (en) A fusion process for producing a compound or an alloy in crystalline form
Tang et al. Growth of a new UV nonlinear optical crystal:: KBe2 (BO3) F2
Morrison et al. The growth of large single-crystal Bi4Ti3O12
US5343827A (en) Method for crystal growth of beta barium boratean
CN101215092B (zh) 具有倍频功能的透红外硫系卤化物玻璃陶瓷及其制备方法
EP0022193B1 (en) Improved process for growing crystal of ktiopo4 and analogues thereof
Kima et al. Growth of lithium triborate crystals by the TSSG technique
US2803519A (en) Method of preparing barium titanate
EP0187843B1 (en) Growth of single crystal cadmium-indium-telluride
KR850000779A (ko) 결정질 폴리포스파이드의 액상성장
JPH07309691A (ja) 結晶の製造方法及び製造装置
US3939252A (en) Dilithium heptamolybdotetragadolinate
JPS6236095A (ja) 有機薄膜結晶の作成方法
Laudise et al. Organo-thermal crystal growth of α6 thiophene
JP2739547B2 (ja) 硼酸リチウム単結晶の製造方法
JPH0469599B2 (da)
KR890005825A (ko) 덴드라이트 웨브 실리콘 결정성장 방법
JP3681441B2 (ja) ＣｓＬｉＢ６Ｏ１０単結晶の製造方法
JPH02279583A (ja) 単結晶育成方法
Quon et al. Growth of orthoferrite single crystals from flux melts
张金平 et al. CRYSTALLOGRAPHIC PARAMETERS AND HEAT PROPERTIES OF 3BaO· 3B_2O_3· 2GeO_2
JPS5532717A (en) Jewelly material

Legal Events

Date Code Title Description
PUP Patent expired